Drug Shortage Report for EPIRUBICIN FOR INJECTION

Last updated on 2019-08-06 History
Report ID 68608
Drug Identification Number 02324091
Brand name EPIRUBICIN FOR INJECTION
Common or Proper name EPIRUBICIN
Company Name TEVA CANADA LIMITED
Active Ingredient(s) EPIRUBICIN HYDROCHLORIDE
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5ML
ATC code L01DB
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-12-01
Estimated end date 2019-07-30
Actual end date 2019-07-30
Shortage status Resolved
Updated date 2019-08-06
Company comments Will be managing inventory to Market. Demand increase cannot be supported in full but will be working closely to support all demand possible.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2019-08-06 French Compare
v12 2019-08-06 English Compare
v11 2019-06-27 French Compare
v10 2019-06-27 English Compare
v9 2019-05-28 French Compare
v8 2019-05-28 English Compare
v7 2019-04-11 French Compare
v6 2019-04-11 English Compare
v5 2018-12-12 French Compare
v4 2018-12-12 English Compare
v3 2018-12-04 French Compare
v2 2018-12-04 English Compare
v1 2018-12-04 English Compare